Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nazik Durdu-Rayman"'
Publikováno v:
Journal of Clinical Nephrology. 5:017-022
Background: Thrombotic microangiopathy (TMA) is a rare and life-threatening complication of prostate carcinoma. Whether plasma exchange has a role in treatment remains a subject of debate. Here we present a case followed by a systematic review of the
Autor:
Klaas G. van der Hem, Kaz Groen, Niels W.C.J. van de Donk, Amanda C. Dijk, Nicole C. H. P. van der Burg-de Graauw, Mark-David Levin, Kazem Nasserinejad, Henriette Levenga, Paula F. Ypma, Aart Beeker, L. Strobbe, Inger S. Nijhof, Harm Sinnige, Claudia A.M. Stege, Saskia K. Klein, Roel J. W. van Kampen, Gerjo A. Velders, Ad Koster, Mels Hoogendoorn, Rineke B. L. Leys, Matthijs Westerman, Gert-Jan Timmers, Pieter Sonneveld, Marjan A. Davidis-van Schoonhoven, Sonja Zweegman, Nazik Durdu-Rayman, Matthijs H Silbermann, Ellen van der Spek, Yavuz M. Bilgin
Publikováno v:
Leukemia, 35(9), 2715-2719. Nature Publishing Group
Stege, C A M, Nasserinejad, K, Klein, S K, Timmers, G J, Hoogendoorn, M, Ypma, P F, Nijhof, I S, Velders, G A, Strobbe, L, Durdu-Rayman, N, Westerman, M, Davidis-van Schoonhoven, M A, van Kampen, R J W, Beeker, A, Koster, A, Dijk, A C, van de Donk, N W C J, van der Spek, E, Leys, R B L, Silbermann, M H, Groen, K, van der Burg-de Graauw, N C H P, Sinnige, H A M, van der Hem, K G, Levenga, H, Bilgin, Y M, Sonneveld, P, Levin, M D & Zweegman, S 2021, ' Improving the identification of frail elderly newly diagnosed multiple myeloma patients ', Leukemia, vol. 35, no. 9, pp. 2715-2719 . https://doi.org/10.1038/s41375-021-01162-z
Stege, C A M, Nasserinejad, K, Klein, S K, Timmers, G J, Hoogendoorn, M, Ypma, P F, Nijhof, I S, Velders, G A, Strobbe, L, Durdu-Rayman, N, Westerman, M, Davidis-van Schoonhoven, M A, van Kampen, R J W, Beeker, A, Koster, A, Dijk, A C, van de Donk, N W C J, van der Spek, E, Leys, R B L, Silbermann, M H, Groen, K, van der Burg-de Graauw, N C H P, Sinnige, H A M, van der Hem, K G, Levenga, H, Bilgin, Y M, Sonneveld, P, Levin, M D & Zweegman, S 2021, ' Improving the identification of frail elderly newly diagnosed multiple myeloma patients ', Leukemia, vol. 35, no. 9, pp. 2715-2719 . https://doi.org/10.1038/s41375-021-01162-z
Autor:
Inge Ludwig, Ellen van der Spek, Paul A F Geerts, Pieter Sonneveld, Margriet Oosterveld, Yavuz M. Bilgin, Savita Soechit, Niels W.C.J. van de Donk, Noortje Thielen, Nicole C H P de Graauw, Mark-David Levin, Gert Jan Timmers, Inger S. Nijhof, Kazem Nasserinejad, Alain Kentos, Marjolein van der Klift, Claudia A.M. Stege, Saskia K. Klein, Esther G.M. De Waal, Matthijs H Silbermann, Maaike Sohne, Marie-Christiane Vekemans, Sonja Zweegman, Roel J.W. van Kampen, Nazik Durdu-Rayman
Publikováno v:
Journal of clinical oncology, Vol. 39, no. 25, p. 2758-2767 (2021)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143
PURPOSE Frail patients with newly diagnosed multiple myeloma have an inferior outcome, mainly because of a high discontinuation rate due to toxicity. We designed a phase II trial specifically for frail patients, evaluating the efficacy and tolerabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd16999f1d8f8fc2bbefd1520cedee3
https://hdl.handle.net/2078.1/261917
https://hdl.handle.net/2078.1/261917
Autor:
Maria B.L. Leijs, Sonja Zweegman, Nazik Durdu-Rayman, Alain Kentos, Saskia K. Klein, Nicole C. H. P. van der Burg-de Graauw, Niels W.C.J. van de Donk, Roel J. W. van Kampen, Noortje Thielen, Koen de Heer, Mark-David Levin, Esther G. M. de Waal, Kazem Nasserinejad, Pieter Sonneveld, Ellen van der Spek, Gert Jan Timmers, Claudia A.M. Stege, Inge Ludwig, Matthijs Westerman, Maaike Sohne, Marie Christiane Vekemans, Yavuz M. Bilgin
Publikováno v:
Blood. 134:695-695
Introduction Elderly non-transplant eligible newly diagnosed multiple myeloma (nte-NDMM) patients also benefit from novel therapies, however, overall survival (OS) is inferior in unfit and frail compared to fit patients as defined by the Internationa